We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cognitive Impairment and Cardiovascular Risk in Older (DECRIVAM)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01327196
First Posted: April 1, 2011
Last Update Posted: September 5, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Grupo de Investigación de Atención Primaria de Castilla y León
Information provided by (Responsible Party):
Luis Garcia Ortiz, Fundacion para la Investigacion y Formacion en Ciencias de la Salud
  Purpose
The objective of this project is to study cognitive yields in people of the town of Salamanca over 65, with particular emphasis on the acquisition of the initial symptoms of cognitive impairment in order to detect mild cognitive impairment and study the relationship between the clinical situation and cardiovascular risk factors. It will depart from a reference population of 420 people older than 65 years living in the municipality of Salamanca which took part in a survey prior to partner health needs of the elderly of 65 years in the municipality of Salamanca. This was a stratified sampling as stratum considering the area of health. The results of this study are expected to evidence the extent of the problem of cognitive decline in the population over 65 years. It is also expected to determine the relationship between the co-morbidity in this problem and specific factors of cardiovascular risk in this group of population.

Condition
Cognitive Impairment Cardiovascular Risk Factor

Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Official Title: Detection of Mild Cognitive Impairment in People Older Than 65 Years of Age and Its Relationship to Cardiovascular Risk Factors (DECRIVAM)

Further study details as provided by Luis Garcia Ortiz, Fundacion para la Investigacion y Formacion en Ciencias de la Salud:

Primary Outcome Measures:
  • Prevalence of risk factors cardiovascular [ Time Frame: Prevalence of risk factors cardiovascular ]

Secondary Outcome Measures:
  • neuropsychological assessment [ Time Frame: neuropsychological assessment ]

Other Outcome Measures:
  • neuropsychological assessment [ Time Frame: neuropsychological assessment ]

Enrollment: 327
Study Start Date: June 2010
Study Completion Date: December 2012
Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
Detailed Description:

A random sample population, the information obtained has a validity superior to other studies in which the sample has not followed very strict criteria of selection.

Protocol for measurement:

  • variable demographic partner
  • vascular risk factors
  • co-morbidity
  • functional level for the activities of daily life
  • cognitive performance in attention, memory, language, praxias, gnosias (abbreviated neuropsychological battery)

Through a battery short neuropsychological specially adapted for the study of older people will carry out a study of the cognitive performance in people older than 65 years of age and will try to establish how much influence the controlled variables of cardiovascular risk.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   65 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
It will depart from a reference population of 420 people older than 65 years living in the municipality of Salamanca
Criteria

Inclusion Criteria:

  • lives in the municipality of Salamanca
  • over 65 years of age
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01327196


Locations
Spain
Fundacion INFOSALUD
Salamanca, Spain, 37007
Sponsors and Collaborators
Fundacion para la Investigacion y Formacion en Ciencias de la Salud
Grupo de Investigación de Atención Primaria de Castilla y León
Investigators
Principal Investigator: MºVictoria Perea-Bartolome, MD Fundacion INFOSALUD
Study Director: Emiliano Rodriguez-Sanchez, MD Fundacion INFOSALUD
  More Information

Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Luis Garcia Ortiz, Fundacion para la Investigacion y Formacion en Ciencias de la Salud
ClinicalTrials.gov Identifier: NCT01327196     History of Changes
Other Study ID Numbers: BIO39/SA04/10
First Submitted: March 30, 2011
First Posted: April 1, 2011
Last Update Posted: September 5, 2014
Last Verified: September 2014

Keywords provided by Luis Garcia Ortiz, Fundacion para la Investigacion y Formacion en Ciencias de la Salud:
dementia
cardiovascular risk
elderly
aging
older 65-100 years

Additional relevant MeSH terms:
Cognitive Dysfunction
Cognition Disorders
Neurocognitive Disorders
Mental Disorders